Prattali Raphael R, Barreiro Guilherme C, Caliseo Caio T, Fugiwara Felipe Y, Ueno Mirian, Prada Patrícia O, Velloso Licio A, Saad Mario J A, Carvalheira José B C
Departamento de Clínica Médica, FCM, Universidade Estadual de Campinas (UNICAMP), 13081-970 Campinas, SP, Brazil.
FEBS Lett. 2005 Jun 6;579(14):3152-8. doi: 10.1016/j.febslet.2005.04.075.
In this study, we demonstrate that pretreatment with aspirin inhibits GH-induced insulin resistance. GH was observed to lead to serine phosphorylation of IRS-1, a phenomenon which was reversed by aspirin in liver, muscle and WAT in parallel with a reduction in JNK activity. In addition, our data show an impairment of insulin activation in the IR/IRS/PI(3)kinase pathway and a reduction in IRS-1 protein levels in rats treated with GH, which was also reversed in the animals pretreated with aspirin. Overall, these results provide new insights into the mechanism of GH-induced insulin resistance.
在本研究中,我们证明阿司匹林预处理可抑制生长激素(GH)诱导的胰岛素抵抗。观察到GH会导致胰岛素受体底物1(IRS-1)的丝氨酸磷酸化,在肝脏、肌肉和白色脂肪组织(WAT)中,阿司匹林可逆转这一现象,同时JNK活性降低。此外,我们的数据显示,在接受GH治疗的大鼠中,胰岛素受体(IR)/胰岛素受体底物(IRS)/磷脂酰肌醇-3激酶(PI(3)激酶)途径中的胰岛素激活受损,IRS-1蛋白水平降低,而在接受阿司匹林预处理的动物中,这些情况也得到了逆转。总体而言,这些结果为GH诱导胰岛素抵抗的机制提供了新的见解。